How do I trace a GL Biochem lot number back to a synthesis date?

This is my second independent submission on material from the same supplier.

I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.

I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer.

So: what is the actual procedure, and which steps matter as opposed to being ritual?

The part that matters: the practical consequence is that spot-testing one vial from a new supplier is better than assuming they are all the same.

Stratified sampling — testing one vial from the top, one from the middle, and one from the bottom of a shipment — is cheap insurance against segregation.

If the entire lot failed qualification, a retest on a different vial is sometimes done, but reporting a retest result under the same lot number is misleading.

Published data on lot homogeneity from manufacturers who sample multiple vials consistently find variation below the published specifications, suggesting the sampling plans work.

One qualification: testing more vials gives better confidence, but at some point the cost outweighs the benefit.

Assume segregation is possible, and design your sampling to catch it if it exists.

The underlying point is that thermal history during shipping is different for every vial, so a lot that experienced thermal abuse may have internal variation even if it was originally homogeneous.

Published segregation failures show that even modern automated processes sometimes produce lots with measurable vial-to-vial variation.

More usefully, testing a vial that has been open in the lab for three months is testing aged material, not the fresh lot, and the result should be explicitly noted as a retest.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

I would treat a "complies with" statement without sampling details as a claim rather than as evidence.

If testing multiple vials, state how many you tested and why you chose those vials.

The failure mode here is publishing a result that applies to the tested vial alone while implying it applies to the entire lot.

Acceptance Sampling by Attributes defines the number of samples you need from a lot to claim a specified quality level at a specified risk — it is in ANSI standard Z1.4.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

edited 14 Oct 2025 by tri_gly_ala — corrected a unit error in the worked example

Batch testing establishes what can be claimed about the lot as a whole, and the sample size determines how much you can actually claim.

For a quantitative result like content, the acceptable range determines how many vials you need to test to establish the lot complies.

The limitation is that you cannot know for certain without testing every vial, and you almost never can afford to do that.

Assume segregation is possible, and design your sampling to catch it if it exists.

edited 12 Nov 2025 by nkem_obiora — added the method parameters